Archivio istituzionale della ricerca dell'Università degli Studi di Palermo
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, pubblicazioni, progetti, attività) adottato dall’Università di Palermo, e ha lo scopo di raccogliere, conservare, documentare, e diffondere ad accesso aperto le informazioni relative alla produzione scientifica degli autori afferenti all’Ateneo.
EnglishThe control of post-operative pain in Italy and other western countries is still suboptimal. In recent years, the Sufentanil Sublingual Tablet System (SSTS; Zalviso; AcelRx Pharmaceuticals, Redwood City, CA, USA), which is designed for patient-controlled analgesia (PCA), has entered clinical practice. SSTS enables patients to manage moderate-to-severe acute pain during the first 72 postoperative hours directly in the hospital setting. However, the role of SSTS within the current framework of options for the management of post-operative pain needs to be better established. This paper presents the position on the use of SSTS of a multidisciplinary group of Italian Experts and provides protocols for the use of this device.
Vergari, A., Cortegiani, A., Rispoli, M., Coluzzi, F., Deni, F., Leykin, Y., et al. (2020). Sufentanil Sublingual Tablet System: from rationale of use to clinical practice. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 24(22), 11891-11899 [10.26355/eurrev_202011_23847].
| Data di pubblicazione: | 2020 | |
| Titolo: | Sufentanil Sublingual Tablet System: from rationale of use to clinical practice | |
| Autori: | ||
| Citazione: | Vergari, A., Cortegiani, A., Rispoli, M., Coluzzi, F., Deni, F., Leykin, Y., et al. (2020). Sufentanil Sublingual Tablet System: from rationale of use to clinical practice. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 24(22), 11891-11899 [10.26355/eurrev_202011_23847]. | |
| Rivista: | ||
| Digital Object Identifier (DOI): | http://dx.doi.org/10.26355/eurrev_202011_23847 | |
| Abstract: | The control of post-operative pain in Italy and other western countries is still suboptimal. In recent years, the Sufentanil Sublingual Tablet System (SSTS; Zalviso; AcelRx Pharmaceuticals, Redwood City, CA, USA), which is designed for patient-controlled analgesia (PCA), has entered clinical practice. SSTS enables patients to manage moderate-to-severe acute pain during the first 72 postoperative hours directly in the hospital setting. However, the role of SSTS within the current framework of options for the management of post-operative pain needs to be better established. This paper presents the position on the use of SSTS of a multidisciplinary group of Italian Experts and provides protocols for the use of this device. | |
| Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| 11891-11899.pdf | Versione Editoriale | Administrator Richiedi una copia |
Copyright © 2021